Cancer Care

CHICAGO — Where does ImClone Systems(IMCL - Cramer’s Take - Stockpickr) stock price go from here?

That’s the most pressing question on many biotech investors’ minds as Monday trading looms after a very busy weekend of new Erbitux clinical data at the American Society of Clinical Oncology (ASCO) annual meeting.
(more…)

When she was a sophomore at Lakewood High School, Kincaid found out she had liver cancer. Doctors said she probably wouldn’t be able to play sports again. The news was devastating.

“I had never been sick and didn’t understand why this was happening to me, especially young as I was,” she said.

Kincaid has beat the odds in her battle with cancer. Through it all, she remained positive by going to schools and teaching children never to give up.
(more…)

A new cousin of the controversial drug Herceptin has opened yet another door to the treatment of breast cancer, it has been revealed.

Like Herceptin, the drug pertuzumab targets the HER-2 gene found in 20% of breast cancer patients.

But while Herceptin blocks a molecular “switch” that promotes cancer growth, the new drug stops the switch being there in the first place. No other drug before it has employed the same mode of action.
(more…)

A drop in the number of breast cancer cases coinciding with a reduction in hormone therapy use is likely to reignite the debate over treatments for women experiencing menopause.

The numbers of Australian women aged over 50 diagnosed with breast cancer has dropped by 7 per cent - equivalent to 600 fewer cases - between 2001 and 2003, during which there was also a 40 per cent decrease in those taking hormone replacement therapy (HRT), a study published in the Medical Journal Of Australia yesterday shows. It was the first time in 20 years the breast cancer rate had declined.
(more…)